BiotechTube
Home/Tivic/Michael K. Handley
MK

Michael K. Handley

Chief Executive Officer

Tivic

Therapeutic Areas

Acute Radiation SyndromeOncology Supportive CareImmunology

Tivic Pipeline

DrugIndicationPhase
EntolimodAcute Radiation Syndrome (ARS)Late-stage (Animal Rule)
EntolastaChronic ApplicationsPre-clinical